Cinnarizine

Cinnarizine is an inhibitor of Calcium Channels and Histamine Receptors used in studies of Calcium Signaling and GPCR Signaling and related signaling programs. In practice, this places the compound in experiments that measure calcium flux, excitability, and secretion-linked signaling and receptor-driven second-messenger signaling and desensitization dynamics in cardiovascular, cell signaling, and inflammation models.

By inhibiting Calcium Channels and Histamine Receptors, Cinnarizine can be used to examine calcium flux, excitability, and secretion-linked signaling and receptor-driven second-messenger signaling and desensitization dynamics. The ion channel annotation adds relevance to electrophysiology, ion-flux, and membrane-potential studies, together with downstream-response mapping in the same experimental setting. In cardiovascular, cell signaling, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Calcium Channels and Histamine Receptors
• Pathway perturbation studies connected to Calcium Signaling and GPCR Signaling and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Electrophysiology, ion-flux, and membrane-potential studies

Overall, Cinnarizine is appropriate when a defined chemical perturbant is needed to connect Calcium Channels and Histamine Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, cell signaling, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.